Search results
Results From The WOW.Com Content Network
The Food and Drug Administration decided that 23andMe’s test and health reports about a person’s predisposition to various diseases circumvented the regulator.
DNA-testing service 23andMe is making substantial efforts to nurse its feeble genetic core back to health. The company will lay off 40% of its workforce, over 200 employees, and cull its therapy ...
23andMe continued to evolve its services, and in 2015, the FDA granted authorization to market its screening for Bloom syndrome, a rare genetic disorder, the company said at the time.
Anne Wojcicki, CEO of 23andMe, the struggling DNA testing company, doesn’t think this is the right time to examine her leadership style.“What will be most interesting is writing the story in ...
Whether your dad's a huge family man or the hardest person ever to shop for, we have a one-size-fits-all gift idea that's perfect for procrastinators. 23andMe DNA kits are 30% off just in time for ...
Genetic testing firm 23andMe said on Monday it is reducing about 40%, or 200 employees, from its workforce and discontinuing further development of all its therapies as part of a restructuring ...
The investors in 23andMe Holding Co. 's ( NASDAQ:ME ) will be rubbing their hands together with glee today, after the... Earnings Release: Here's Why Analysts Cut Their 23andMe Holding Co. (NASDAQ ...
(Reuters) - Genetic testing firm 23andMe Chief Executive Officer Anne Wojcicki would no longer be open to considering third-party takeover proposals for the company, a regulatory filing showed on ...